Becton Dickinson Share Holder Equity 2010-2024 | BDX
Becton Dickinson share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Becton Dickinson share holder equity for the quarter ending September 30, 2024 was $25.868B, a 0.27% decline year-over-year.
- Becton Dickinson share holder equity for 2023 was $25.796B, a 2.03% increase from 2022.
- Becton Dickinson share holder equity for 2022 was $25.282B, a 6.78% increase from 2021.
- Becton Dickinson share holder equity for 2021 was $23.677B, a 0.37% decline from 2020.
Becton Dickinson Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$25,796 |
| 2022 |
$25,282 |
| 2021 |
$23,677 |
| 2020 |
$23,765 |
| 2019 |
$21,081 |
| 2018 |
$20,994 |
| 2017 |
$12,948 |
| 2016 |
$7,633 |
| 2015 |
$7,164 |
| 2014 |
$5,053 |
| 2013 |
$5,043 |
| 2012 |
$4,136 |
| 2011 |
$4,828 |
| 2010 |
$5,435 |
| 2009 |
$5,143 |
Becton Dickinson Quarterly Share Holder Equity
(Millions of US $) |
| 2024-06-30 |
$25,868 |
| 2024-03-31 |
$25,647 |
| 2023-12-31 |
$25,332 |
| 2023-09-30 |
$25,796 |
| 2023-06-30 |
$25,937 |
| 2023-03-31 |
$25,689 |
| 2022-12-31 |
$25,472 |
| 2022-09-30 |
$25,282 |
| 2022-06-30 |
$25,493 |
| 2022-03-31 |
$24,525 |
| 2021-12-31 |
$24,160 |
| 2021-09-30 |
$23,677 |
| 2021-06-30 |
$24,135 |
| 2021-03-31 |
$24,826 |
| 2020-12-31 |
$24,663 |
| 2020-09-30 |
$23,765 |
| 2020-06-30 |
$24,022 |
| 2020-03-31 |
$20,951 |
| 2019-12-31 |
$21,202 |
| 2019-09-30 |
$21,081 |
| 2019-06-30 |
$21,497 |
| 2019-03-31 |
$21,309 |
| 2018-12-31 |
$21,404 |
| 2018-09-30 |
$20,994 |
| 2018-06-30 |
$21,357 |
| 2018-03-31 |
$21,152 |
| 2017-12-31 |
$21,247 |
| 2017-09-30 |
$12,948 |
| 2017-06-30 |
$12,587 |
| 2017-03-31 |
$7,963 |
| 2016-12-31 |
$7,583 |
| 2016-09-30 |
$7,633 |
| 2016-06-30 |
$8,033 |
| 2016-03-31 |
$7,666 |
| 2015-12-31 |
$7,223 |
| 2015-09-30 |
$7,164 |
| 2015-06-30 |
$7,253 |
| 2015-03-31 |
$7,159 |
| 2014-12-31 |
$5,068 |
| 2014-09-30 |
$5,053 |
| 2014-06-30 |
$5,378 |
| 2014-03-31 |
$5,315 |
| 2013-12-31 |
$5,078 |
| 2013-09-30 |
$5,043 |
| 2013-06-30 |
$4,717 |
| 2013-03-31 |
$4,589 |
| 2012-12-31 |
$4,469 |
| 2012-09-30 |
$4,136 |
| 2012-06-30 |
$4,235 |
| 2012-03-31 |
$4,476 |
| 2011-12-31 |
$4,728 |
| 2011-09-30 |
$4,828 |
| 2011-06-30 |
$5,298 |
| 2011-03-31 |
$5,099 |
| 2010-12-31 |
$4,878 |
| 2010-09-30 |
$5,435 |
| 2010-06-30 |
$5,154 |
| 2010-03-31 |
$5,150 |
| 2009-12-31 |
$5,260 |
| 2009-09-30 |
$5,143 |
| 2009-06-30 |
$5,212 |
| 2009-03-31 |
$4,804 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
